Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections

https://doi.org/10.1016/S0277-5379(98)90033-5Get rights and content

Abstract

A pilot study with amphotericin B incorporated in sonicated liposomes (ampholiposomes) made of egg phosphatidylcholine, cholesterol and stearylamine in a molar ratio 4:3:1 was performed in cancer patients with fungal infections. Fifteen patients received a total of 117 intravenous infusions of ampholiposomes. The total dose of amphotericin B administered per patient ranged from 20 to 1004 mg (mean 472 mg). The number of infusions per patient varied from 1 to 20 (mean 8) and the duration of treatment from 1 to 29 days (mean 10 days). Infusion of doses up to 1.8 mg/kg was well tolerated. None of the common side-effects of Fungizone®, the colloidal suspension of amphotericin B, occurred; it was noteworthy that patients had no renal function impairment.

Serum amphotericin B concentrations given as ampholiposomes were much higher than those obtained with Fungizone®. With a daily treatment schedule, peak and trough serum amphotericin B concentrations, as measured by HPLC, were 10 to 20 μg/ml and 5 to 10 μg/ml respectively; while they did not exceed 2 μg/ml and 1 μg/ml with Fungizone®. Amphotericin B given as ampholiposomes had a prolonged serum B half-life (25.3 ± 16.0 h). Higher serum antifungal activity was observed with ampholiposomes as compared to Fungizone®. We concluded that ampholiposomes have a better therapeutic index than Fungizone®.

References (34)

  • A Coune et al.

    Iv administration of a water-insoluble antimitotic compound entrapped in liposomes

  • JP Sculier et al.

    Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent

  • JF Cooper et al.

    The limulus test for endotoxin (pyrogen) in radiopharmaceutical biological

    Bull Parent Drugs Assoc

    (1972)
  • JP Labaume

    Pharmacocinétique, Principes Fondamentaux

    (1984)
  • DD Bindschalder et al.

    A pharmacologic guide to the clinical use of amphotericin B

    J Infect Dis

    (1969)
  • F Meunier

    Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents

    Eur J Clin Microbiol

    (1986)
  • K Godfrey

    Comparing the mean of several groups

    N Engl J Med

    (1985)
  • Cited by (124)

    • Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicity

      2022, Asian Journal of Pharmaceutical Sciences
      Citation Excerpt :

      Toxicity of lipid formulations was also shown to depend on particle size and lamellarity [40–43], on the nature of and relative concentration of the sterol(s), and the drug-to-lipid ratios [44–46]. Studies on these parameters involved in vivo studies (mice or rats), in vitro cell lines [47,48] and surrogate toxicity testing systems like potassium release in erythrocytes [28,49], or artificial system models for toxicity [15,50]. While the effects of the lipids on toxicity may be partially derived from influencing the equilibria amongst different aggregate forms in the liposomes, this could also be related to liposome-cell (membrane), liposome-lipoprotein, and liposome-albumin interactions in vivo (affecting pharmacodynamics and pharmacokinetics).

    • Spectroscopic, molecular dynamics simulation and biological studies of Flavin MonoNucleotide and Flavin Adenine Dinucleotide in biomimetic systems

      2021, Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
      Citation Excerpt :

      Lipidic bilayer structure as the structural basis for cell membrane has charged groups of different natures, like charged or zwitterionic lipid head-groups, water dipoles and dipolar lipid residues, not uniformly distributed through membrane [22]. In these lines, it was reported that egg lecithin has an important role as vehicles for delivery of drugs and molecules of biological interest to a desired site in the living organism as well as a membrane model for the study of lipid peroxidation [23–25]. Phosphatidylcholine has an important role in metabolic pathways with lipidic membranes acting as mediators, changes in membrane architecture and endothermic properties affecting biological functions that occur at the cellular membrane level [26–28].

    • NMR and ESR study of amphotericin B interactions with various binary phosphatidylcholine/phosphatidylglycerol membranes

      2017, International Journal of Pharmaceutics
      Citation Excerpt :

      In fact, the term liposomal vesicle is a very unprecise and coarse definition. The type of liposomal vehicle (Sculier et al., 1988) (chemical composition, charge, structure, and mode of preparation) can strongly modify the physicochemical, biological, and pharmacological properties of liposomes and thus of the carried drug. These aspects had been evoqued under the scope of solubilization, transfer of AMB from vesicle to cell membrane ability, and size of liposome-AMB preparations.

    • Spontaneous formation of vesicles

      2006, Advances in Colloid and Interface Science
      Citation Excerpt :

      Due to the ability of embedding the drug into the inner part of liposomes, many drugs were better prepared. In the 1980s, investigations were focused on applications requiring injection of liposomes into the blood circulation, and liposomes delivery directly to the specific location [36–45]. When delivered systemically, liposomes are subjects to distribution by the circulatory system, and they are rapidly eliminated by the liver.

    View all citing articles on Scopus

    This work was presented in part at the 22nd meeting of the American Society of Clinical Oncology (Los Angeles, 1986).

    This work was supported in part by the ‘Fondation Lefevre’ (Belgium), the Squibb Company (U.S.A.) and the ‘Fonds National de la Recherche Scientifique’ (Belgium).

    View full text